Carbapenemase-resistant Enterobacteriaceae represent a major public health concern worldwide due to their broad spectrum of resistance. Development of new rapid diagnostic tests to track antimicrobial resistance patterns is considered as one of the priority core action by international experts and health authorities.

Carbapenemase-resistant Enterobacteriaceae represent a major public health concern worldwide due to their broad spectrum of resistance. Development of new rapid diagnostic tests to track antimicrobial resistance patterns is considered as one of the priority core action by international experts and health authorities.

PerioSafe is an immunological rapid test for the qualitative detection of activated matrix metalloproteinase-8 (aMMP-8) in a mouthwash sample.

aMMP-8 is an early risk marker for hidden reduction of gingival, periodontal and / or peri-implant soft and hard tissue – it is present before signs of inflammation become clinically visible or an attachment loss occurs. The PerioSafe rapid test provides evidence on the risk of progressive destructive disease of the periodontium possibly weeks or months before the need for an X-ray becomes apparent. The aMMP-8 test therefore fills the gap between conventional diagnostic methods such as BOP, probe, X-ray, and bacterial tests.

Implant Safe is an immunological rapid test for the qualitative detection of aMMP-8 in gingival crevicular fluid (GCF) or a peri-implant sulcus fluid (PISF).

PerioSafe and Implant Safe are both based on a lateral flow immunoassay and use a monoclonal antibody known as 8706 or 8708^th developed by Prof. Dr. Timo Sorsa, University of Helsinki.

Adenoviruses are a group of viruses responsible for a wide range of infections, mostly respiratory and gastroenteric diseases. Immunochromatography is the most preferable method for diagnosing respiratory adenoviral infections due to its simplicity, short time-to-results and high sensitivity. This method is used to test nasopharyngeal secretions (swabs, aspirates and washes) or culture supernatant.

Respiratory influenza types A and B are highly contagious viral infections of the upper respiratory tract, causing severe complications. Children, pregnant woman, elderly people and patients with chronic respiratory diseases are particularly at risk. Quick time-to-result is critical for a fast treatment decision to be made. This can be achieved with the use of rapid, specific and sensitive antigen detection tests.

Respiratory Syncytial Virus (hRSV) is a major cause of respiratory illness in people of all ages. It represents the most frequent cause of serious respiratory tract infections in children under 4 years, in elderly and immunocompromised patients, and is associated with high death rates. Rapid antigen tests are widely used to detect hRSV because they are convenient and easy to perform for fast, individual screenings.

Clostridium difficile is an anaerobic bacteria acting as an opportunistic pathogen in the intestine. Toxinogenic strains of Clostridium difficile cause infections from mild-diarrhea to pseudomembranous colitis, potentially leading to death. Clostridium K-SeT allows the specific detection of C. difficile’s GDH (Glutamate Dehydrogenase) in stool specimen.

Helicobacter pylori causes peptic ulcer disease, chronic gastritis and it is also strongly associated with gastric malignancies and has been classified as a class I carcinogen. The high incidence of this infection in the population and the consequences that follow justify the use of a rapid diagnostic tool against this bacterium.

Quantitative suPARnostic® Quick Triage System is a Point of Care Test Device for early warning and patient triaging. The quantiative suPARnostic® Quick Triage is an easy-to-use test that will allow clinicians to obtain a faster patient triage.

PT Monitor® is a competitive immunoassay in rapid test format for the quantitative determination of DRH1 antibody equivalents in serum using the antibody clone DRH1.

The antibody concentration is associated with HPV16 induced precancerous lesions and tumors which are usually located in the oral an pharyngeal and anogenital area. PT Monitor® is a single use test which is dedicated to professional users.